- Home
- NSTS vs NOTV Comparison
NSTS vs NOTV Comparison
Compare NSTS & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NSTS | NOTV |
|---|---|---|
| Founded | 1921 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.7M | 29.9M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | NSTS | NOTV |
|---|---|---|
| Price | $11.66 | $0.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 5.6K | ★ 1.6M |
| Earning Date | 11-13-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $9,762,000.00 | ★ $513,024,000.00 |
| Revenue This Year | N/A | $6.26 |
| Revenue Next Year | N/A | $45.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 57.78 | 4.54 |
| 52 Week Low | $10.72 | $0.66 |
| 52 Week High | $13.32 | $6.48 |
Technical Indicators
Market Signals| Indicator | NSTS | NOTV |
|---|---|---|
| Relative Strength Index (RSI) | 66.32 | 37.72 |
| Support Level | $11.14 | $0.79 |
| Resistance Level | $11.75 | $0.95 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 88.00 | 51.55 |
Price Performance
Historical ComparisonAbout NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.